Analyse Technique et Conseils Boursiers


Source : Reuters lire le PDF

Shares in Fresenius Medical Care fall 1.1 percent in robust volume, extending losses into a fourth straight session and underperforming a 0.2 percent rise for the European healthcare sector, after the world's largest dialysis company reports slightly disappointing earnings.

The introduction of a new reimbursement system in the United States, designed to encourage clinic operators to reduce costs and use drugs more sparingly, resulted in lighter-than-expected U.S. revenue per treatment for the German group, JPMorgan says.

Méthodologie d’analyse
Méthodologie de recommandation
Conditions d'utilisation
Carrières et Formation